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Fig. 1 Polyamine metabolic pathway
Orn; Ornithine, ODC; Ornithine decarboxylase, Put; Putrescine, SpdSyn; Spermidine synthase, Spd; 
Spermidine, SpmSyn; Spermine synthase, Spm; Spermine, SSAT; Spermidine/spermine N1–acetyltransferase, 
PAO; Acetylpolyamine oxidase, SMO; Spermine oxidase, AcSpd; N1-Acetylspermidine, Acspm; N1–
Acetylspermine, AdoMet; S-Adenosylmethionine, AdoMetDC; S-Adenosylmethionine decarboxylase, 
deAdoMet; Decarboxylated-S-Adenosylmethionine, MTA; 5’- Methylthioadenosine 
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Fig. 2  Changes in Spm / Spd ratio and SSAT activity of 3T3-L1 during differentiation with IBMX, 
DEX and INS. 
Spm / Spd ratio (A) and SSAT activity (B) in 3T3-L1 cells at indicated times from day 0 to day 4 were 
measured.  Results shown for control cells stimulated with IBMX, DEX and INS (○) and blank cells without 
the stimulus (●) at times shown after start of stimulation.  Results represent the mean ± S.E..  *** p < 0.001, 
** p < 0.01, * p < 0.05 compared with control.
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Fig. 3  The effect of APCHA or MCHA on adipocyte differentiation.  
Spm/Spd ratios (A) and SSAT activity (B) in 3T3-L1 cells treated with MCHA or APCHA for day -3 to day 
11 were measured during differentiation.  Results shown for control cells (○ with solid line), MCHA-treated 
cells (□ with solid line) and APCHA-treated cells (▲ with dotted line).  (C) Cells were stained with Oil Red 
O at day 10 after the stimulus.  (D) TG contents were measured at day 11.  (E) GPDH activity was measured 
at day 7.  Results represent the mean ± S.E..  *** p < 0.001, ** p < 0.01, * p < 0.05 compared with control.
??????????????????????????








????????? SSAT ??????????? APCHA ???????????
???????????????APCHA ???????????????????
?????????????????????????PAO ??? SMO ?????
????? MDL72527 ????????????????? N-acetylcysteine (NAC) 
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MDL72527 ??? NAC ????????????? Spm ???????????
??? (Fig. 4)?
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Fig. 4  The effect of MDL72527 and NAC on APCHA-enhanced differentiation of 3T3-L1 cells. 
Cells were treated with MDL72527 (5 µM) in the presence or absence of APCHA.  Cells were pretreated 
with NAC (5 mM) 1 day prior to induction for differentiation.  (A) spermine/spermidine ratios, (B) 
Triglyceride contents at day 11 and (C) GPDH activity at day 8 were analysed after stimulus for 
differentiation.  Results shown for control cells (○ with solid line), treated with APCHA (▲ with dotted 
line) and MDL72527 (◆ with solid line), MDL72527 with APCHA (◆ with dotted line), NAC (◇ with solid 
line) and NAC with APCHA (◇ with dotted line).  Results represent the mean ± S.E..  *** p < 0.001, ** p < 
0.01, * p < 0.05 compared with control.  ### p < 0.001, ## p < 0.01, # p < 0.05 compared with APCHA-
treated cells.  ¶¶ p < 0.01 compared with NAC-treated cells.  N.D., not detectable.
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Fig. 5  The effect of MCHA or APCHA on lipid accumulation in mature adipocytes.  
The differentiated cells were treated with MCHA or APCHA from day 6.  Results shown for control cells (○ 
with solid line), MCHA-treated cells (□ with solid line) and APCHA-treated cells (▲ with dotted line).  Spm/
Spd ratios (A) and SSAT activity (B) were measured at indicated times from day 6 to day 11.  (C) The effect of 
inhibitors on lipid accumulation.  Cells were fixed and stained with Oil Red O at day 10.  (D) Triglyceride 
contents at day 11 and (E) the activity of GPDH at day 14 were measured.  Results represent the mean ± S.E..  
*** p < 0.001, ** p < 0.01, * p < 0.05 compared with control.
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Fig. 6  The effect of BENSpm on lipid accumulation.  
Triglyceride contents in (A) differentiating cells and (B) mature cells treated with BENSpm were shown. 
Results represent % of control.
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?????? 600 ?????????? (Table 1) ?
???????????????? BENSpm ??? APCHA ??????????
??????????????????????? BENSpm ??????????




?? SpmSyn ??? Spm ?????????????????????????
19
Table 1  The effect of BENSpm on SSAT activity.  
???????
?????????????????????????????????????
??????????MCHA ??? APCHA ?????????????????
????????????????????? MCHA ???????????
??APCHA ????????????????????????????????
???????APCHA ?????????? SSAT ????????APCHA ??
?????????????????????BENSpm ???? SSAT ??????
?????????????????????????????????????
???APCHA ??????????????? SSAT ????????????
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?? 1 mM ????????????????24 ???????????????
??? TG ??? 2.5 ????? [22]?????????????????HepG2 
???????????????Hozumi ???? [23] ????????????
???? (-1 ??) ? FBS ?????????? (BSA) ????????????
??0 ??????????????????????????????????
??????????????????????????????????Oil Red 
O ???????????20 µM ?? 1 mM ?????????????????
????????200 µM ?????????????????????????
?? Oil Red O ????????????? (data not shown)??????????
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? 1.15 ??????????? (Fig. 7)????????????????? 3 ?
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?????????????????????????????????????
????????????????????
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?HepG2 ??????????????SpdSyn ??? SpmSyn ?????????
????????????????????????MCHA ??? APCHA ???
?????????????????????????????????????
???????????????20 µM ????????????????????
?????????????????????????????? 5 ?? (-5 ??) 
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Fig. 7  Changes in polyamine contents and polyamine synthase activity of HepG2 treated with oleic 
acid. 
Results shown for stimulate lipid accumulation for oleic acid (○) and without oleic acid (●) in cells at times 
after treatment.  Spermidine (A), Spermine (B) contents, Spermidine synthase (C) and Spermine synthase 
(D) acticity were measured at indicated times from day 0 to day 3.  Results represent the mean ± S.E.. * p < 
0.05 compared with control.
????????-4 ??? 20 µM MCHA ??? APCHA ????????????
??-1 ??????????? 5% BSA ???????????????? 24 ??
? (0 ??) ???????????Oil Red O ?????????????????
????????????????????????MCHA ????? Spd ?? 
50% ??????Spm ?? 1.3 ??????APCHA ????? Spm ?? 20% ??
????Spd ?? 3 ???????????????? MCHA ?????????
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Fig. 8  The effect of APCHA on lipid accumulation in HepG2 cells.
To induce lipid accumulation by addition of Oleic acid.  APCHA was treated from -4d (APCHA from -4d) 
or administered simultaneously with Oleic acid (APCHA from 0d).  Cells were fixed and stained with Oil 
Red O at 1 day.
Fig. 9  Changes in SSAT activity in HepG2 cells treated with oleic acid. 
Results shown for stimulated lipid accumulation with oleic acid (○ with solid line) and without oleic acid 
(● with solid line) and APCHA-treated cells (?with dotted line) in HepG2 cells at times shown after start 
of stimulation.  Results represent the mean ± S.E..  * p < 0.05 compared with control.
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Fig. 10  Cellular morphology during C2C12 cell differentiation.
Cells were fixed and stained with Hematoxylin.
???????????????????? (Fig. 11)?Cervelli ?? SSAT ????
????? SSAT ???????????? [19]????????????????
????????????????????????????????Cervelli ??
????? HS ???? FBS ????????????????????????
????????????
?(3)??????????????????????????
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Fig. 11  Changes in polyamine contents and SSAT activity in C2C12 cells during myogenic 
differentiation.
(A) Spermidine and (B) Spermine contents.  (C) SSAT activity.  Results shown for differentiation medium 
(○) and  growth medium (●) on C2C12 cells at times shown after medium replacement.  Results represent 
the mean ± S.E..  * p < 0.05 compared with control.
 C
???? control ????? Spm ??????Spd ?????????????? 
APCHA ?????????control ????? Spm ??????Spd ???????
?????? C2C12 ????????????????????????
?????? 4 ????????? CK ???????????????????
???????????? CK ??? control ??????APCHA ?????? 25% 
?????????? MCHA ?????? 50% ???????? (Fig. 12)????
???????APCHA ????? control ??????????????????
?? MCHA ?????????????????? (Fig. 12)??????????
??????????????????????????????????????
???????????????????????????? control ??????
?????????????????CK ??????????????? CK ??
???????????????
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Fig. 12  The effect of MCHA or APCHA on C2C12 cells differentiation.
The activity of CK at day 4 were measured. (A) C2C12 cells were treated with MCHA or APCHA from day 
-2 to day 4.  (B) Cells were stained with Hematoxylin..  Results represent the mean ± S.E..  ** p < 0.01 
compared with control
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?????? (Fig. 13)????????????????????????????





Fig. 13  The effect of polyamine on 
C2C12 cells differentiation.
The activity of CK at day 4 were 
measured.  Results represent the mean ± 
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Fig. 14  Lipid accumulation in C2C12 cells stained by Mayer’s Hematoxylin and Oil Red O.
(a) Oil Red O stained for 5 min  (b) Oil Red O stained for 30 min  (c) Mayer’s Hematoxylin and Oil Red O 
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Fig. 15  The effect of GlcN on polyamine contents in C2C12 cells.
(A) Spermidine contents and (B) Spermine contents in C2C12 cellls were measured. Results shown for 
stimulated lipid accumulation for GlcN (○ with solid line) and control cells without GlcN (● with solid line) 
in C2C12 cells at times shown after start of stimulation.  Results represent the mean ± S.E..  *** p < 0.001, 
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Fig. 16  Effect of GlcN, polyamine on lipid accumulation in C2C12 cells.






HepG2 ?????????????????? C2C12 ?????????????
????????????????????????
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?C2C12 ????????????????Spd ???????Spm ??????
?????????????????? SSAT ???????????MCHA ??
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Fig. 17  Effect of APCHA on lipid accumulation in C2C12 cells.
Cells were fixed and stained with Hematoxylin and Oil Red O at day 6. 
? APCHA ??????????????????????CK ?????????
?? CK ????Spd ????????????????????????????
????????????????????????
?C2C12 ???? GlcN ??????????????Spm ??????????
????????????????GlcN ?????????????????? 
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?????????????????????????????? [10] ??3T3-L1 
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SpmSyn ????????????????????????????SpmSyn ??
??????????????????????????????????
?????????????????? SpmSyn ????? Spm ????????




?3 ???4 ????? 11 ??? Normal ?????? Gy ?????????? 
Folch ?????????????? TG ????????? (Cho) ???????
? (NEFA) ?????????????????????Gy ???? Normal ???
?????????
?(1)?Gy ?????? TG ?
?3 ??? Gy ???? Normal ????????????????? TG ?? 62% 
????????????? (Fig. 18) ?4 ??? 40% ????11 ???? 71% ??
?????????????? TG ??????3 ???? 60% ?????????
?????4 ??? 36% ????11 ???? 68% ???????Gy ??????
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? TG ???????????????? Normal ???????????????
?????????????????3 ??????????? TG ???????
?????????????????
?(2)?Gy ?????? Cho ?
????? Normal ? 100% ???????????? Cho ???????????
????? Cho ?????????Normal ???? Gy ????????????
??? Cho ??????????????? (Fig. 19) 
?(3)?Gy ?????? NEFA ?
????? Normal ? 100% ????????????? NEFA ???????Gy 
???? Normal ????????3 ???? 31% ????4 ???? 21% ??
??11 ???? 55% ??????????? (Fig. 20)?
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Fig. 18  TG contents in liver of 
Gy and Normal mice.
Results represent the mean ± S.E.. 
** p < 0.01, * p < 0.05 compared 
with control.
Fig. 19  Cho contents in liver of 
Gy and Normal mice.
Results represent the mean ± S.E.. 
** p < 0.01, * p < 0.05 compared 
with control.
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?3 ??? Normal ????? Gy ?????????? CK ?????????
??Gy ???? CK ???? Normal ?????? ? 20% ??????????? 
(Fig. 21)???????C2C12 ????????????????? APCHA ???
??????????????????? Normal ???? Gy ?????????
??? CK ???????????? Normal ?????????????????
???????
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Fig. 20  NEFA contents in liver of 
Gy and Normal mice.
Results represent the mean ± S.E.. 




????????????????? Normal ????????Cho ???????
???TG ??? NEFA ???????????????????????????
???Gy ???????? SpmSyn ?????????????? Spm ????
?????????????????????????????????????
???? HepG2 ???? APCHA ??????? SpmSyn ???????????
?????????????????? SpmSyn ??????????????
?????????? TG ?? Normal ???????????????? CK ??
? Gy ????????????????CK ?????????????????
??????????????????? Cr + MgATP2- → PCr2- + MgADP- + H+ ??
????????? ATP ??????????????????????????
????? CK ???????????????????????????????
? CK ????????????????? [39]????????Gy ??????
????CK ???????????? Normal ????????????????





Fig. 21  TG contents and CK activity in muscle of Gy and Normal mice.
(A) TG contents (B) CK activity







??????? 3T3-L1 ?????????? HepG2 ?????????????
C2C12 ??????????????????????????????????
????????????????? MCHA ? APCHA ????????????
????????????????? Spd ? Spm ??????????????
??Spd ??? Spm ????????????????????????????
???????????????????????????????
???????3T3-L1 ??????????????? Spd/Spm ?????? 
SSAT ????????????????????? MCHA ???????
??APCHA ?????????????????APCHA ?????? SSAT ??
????????????














APCHA ??????????APCHA ???????SSAT ?????????
??SpmSyn ?????????? Spm ??????????????????
????????????? Spm ???????????????????
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?????????????? HepG2 ????????????? C2C12 ????
??????????????????????HepG2 ???????????? 
Spd ? Spm ??????????SpdSyn ? SpmSyn ??????????????
???????APCHA ????????????????????????? 
HepG2 ????????? Spm ???????? SpmSyn ??????????
????? APCHA ???? Spm ???????????????????APCHA 
??????????????????????????????
?C2C12 ????????????????Spd ?????Spm ???????
??????????? MCHA ??????????APCHA ?????????
?????? CK ??????????????C2C12 ????????????
????????????????????? C2C12 ??? GlcN ???????
??????????Spm ?????????????????????????




??????? SpmSyn ????? Spm ???????????????????
?????Normal ???????? TG ??NEFA ???????????????
????????????????HepG2 ???? APCHA ??????? ???
??????????????????? SpmSyn ?????? Spm ??????
?????????
????Gy ???????????TG ???? CK ?????????????
????CK ????????????????????????????????
??????? Gy ??????????CK ???????????? Normal ?
??????????????????????? TG ?????????????







SpmSyn ????? Spm ??????????????????????????
??????Gy ??????????????????????????????
?????????????? GPDH ????????? [15] ?????????

















































dansylnorspermine ?????????????????PBS ??????? ???
???????? CoA ? SIGMA ??HPLC ??????? ??????????
????????????????????????? IBMX?INS?DEX ????
????????DMEM ????????????????????? Gibco ??
?????? ??????? milliQ ??????C2C12 ????????????
?????????????????????????
????




?10% CS ??? DMEM (????????? 3.7 mg/mL + ????? 50 unit/mL+?
???????????) ?????????????? 2 ???????????
???????10% FBS ??? DMEM ???????? 0.5 × 104 cells/cm2 ????
??????3 ????????????????????????? (0 ??) ??
????????????????0.5 mM IBMX ? 1 µM DEX ?????????
??2 ?? (2 ??)?10 µg/mL INS?????????????? 2 ?? (4 ??) 
10% FBS ?? DMEM ?????? 2 ?????????? ??????????
?????0 ???? 4 ?????? 10% FBS ?? DMEM ???????
46
2?HepG2 ??
?10% FBS ??? DMEM (????????? 3.7 mg/mL?????? 50 unit/mL ?
?????????? 50 unit/mL ???) ?????????? 1.0 × 104 cells/cm2 ?
?????????3 ????????????????????????????
???????????? 5% BSA ??? DMEM ??????? (-1 ??)????
? (0 ??)?1 mM ???????? 5% BSA ????????????????24 
????????3 ???????????
3?C2C12 ??
?10% FBS ??? DMEM (????????? 3.7 mg/mL?????? 50 unit/mL?
?????????? ? 50 unit/mL ???) ?????????????????? 
0.16 × 104 cells/cm2 ???????????3 ?????????????????
????????? (0 ??) ?????
?????????????0 ????????????????? 5 % HS ??? 
DMEM ????????????? 24 ?????????
?????????0 ?????????????? 2% HS ??? DMEM?? 
GlcN ????????????????GlcN ????????????? 24 ??
????????????
Oil Red O ??
?0.15 g ? Oil Red O ? 50mL ?????????????????Oil Red O ???
???????????Oil Red O ???:?=3: 2 ?????10 ???????? 
0.45 µm ????????????????????
?????????????????????4% ??????? ? PBS ????
?????? 30 ?????????????? PBS ??? 2 ?????Oil Red O 
?????????????????????????? PBS ? 2 ???????
47
?????????????? 3T3-L1 ??? 5 ??HepG2 ??? 60 ℃ ?????
?? 10 ???C2C12 ??? 30 ??????
Mayer’s Hematoxylin - Oil Red O ???
?Mayer’s Hematoxylin ?? ? 0.45 µm ????????????????????
??Oil Red O ?????????????? Oil Red O ???????????
???????????????? 4 ? ????????????????? 30 ?
????????????????Mayer’s Hematoxylin ????????????3 
???????????????Oil Red O ??????????????????
30 ???????
????????
?????????????????PBS 1 mL ???? 2 ????????
??10% TCA????????????????????????????????
????????13,000 × g??20 ??????????????? 1.5 ml ????
?????????HPLC ??????????????0.1 M ???????? 
200 µL ?????????????????????Bradford ????????
??????????????????? HPLC ????????????? OPA 
?????????????????? 12.5% ?????????????? (5N 
NaOH ? pH 5.5 ???????) ??????????????????? 0.3 mL/
min?OPA ? 0.2 mL/min ???????????????????? 345 nm???
?? 445 nm ????????? 70 °C ???????????????????? 
LC-6A ? LC-7A (?????????) ??????????? RF530 (??????
???) ??????????? MCI GEL CK10S (????????) ?? ????




???7% ??????????????????OPA ?????? HPLC ????
?????????????????
SSAT ???? [32]
???????????????? PBS 1 mL ? 2 ??????SSAT homogenate 
buffer (1 mM EDTA?10 mM Tris HCl?4°C?pH 7?2.5 mM DTT)?????????
??????????????????????????????? 10 ?????
??????????? 4 °C?13,000 x g? 20 ????????????????
????
?????40 µM N1- dansylnorspermine?50 M acetyl-CoA ?????? 200 µL (??
?????? 50 µg) ?????37 °C? 10 ???????????????100% 
TCA 23 µL ???????????13,000 x g?20 ?????????? 100 L ??
?? HPLC ?????????
????????TFA 0.1%??????????????? 25 mM?MeOH (v/v) 73 
% ????????????????????:TSKgel ODS 80TS (TOSOH) φ 4.6 mm 
× 150 mm???:0.5 mL/min????? 333 nm????? 544 nm ?????:45 °C ?
???
SpdSyn ?? SpmSyn ????
?????????????????PBS 1 mL ??? 2 ?????PBS 100 µL ??
?????????????????????????????????????? 
10 ???????????????? 4 ℃?10,000 × g?20 ??????????
???????????SpdSyn ????????1 mM ????? (Put) ?? 
SpmSyn ?????? 0.5 mM APCHA?SpmSyn ????????5 mM Spd ?? 
SpdSyn ?????? 0.5 mM MCHA ????0.1 mM AdoMet?0.6 mM ??????
?????? 0.1 M ??????? ( pH 7.5 )?37 ℃ 1 ??????????
??SpdSyn ???????APCHA ??????? SpmSyn ??? dcAdoMet ??? 
49
MTA ???????SpmSyn ?????? MCHA ??????? SpdSyn ???
??SpdSyn ??? dcAdoMet ??? MTA ?????????????????? 
MTA ????????????????????????? MTA ???? 1.5 M ?
??????????????70 ℃?15 ???????????????? 1, N6 -
???????????????? HPLC ????????
?????????????????
?Folch ????????????????????? TG ??Cho ??? NEFA ?
?????????????? E-?????????????? E-????
???NEFA C-?????? (?????? (?) ) ?????????
CK ????
??????????PBS 2 mL ??? 2 ?????PBS 200 µL ?????????
??????????????????????????????? 10 ?????
??????????? 4 ℃?13,000 × g ?20 ????????????????
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